Midsize pharma company stabilizes API - Accelerates time to clinic from three months to three weeks

Case study

A midsize pharma company wanted to progress its therapy from early development to late-phase clinical trial stage, but needed a CDMO partner to provide support in formulation analysis so that it could stabilize its product and successfully reach its clinical studies milestones.